Yan B - Search Results

1

Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy.

Xu Y, Hu Y, Xia H, Zhang S, Lei H, Yan B, Xiao ZX, Chen J, Pang J, Zha GF. Xu Y, et al. Among authors: yan b. Adv Healthc Mater. 2024 Feb;13(5):e2302691. doi: 10.1002/adhm.202302691. Epub 2023 Nov 29. Adv Healthc Mater. 2024. PMID: 37990414

2

Screening of pH-responsive long-circulating polysaccharide-drug conjugate nanocarriers for antitumor applications.

Zhang X, Li D, Huang J, Ou K, Yan B, Shi F, Zhang J, Zhang J, Pang J, Kang Y, Wu J. Zhang X, et al. Among authors: yan b. J Mater Chem B. 2019 Jan 14;7(2):251-264. doi: 10.1039/c8tb02474j. Epub 2018 Dec 12. J Mater Chem B. 2019. PMID: 32254550

3

Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.

Shi L, Yan Y, He Y, Yan B, Pan Y, Orme JJ, Zhang J, Xu W, Pang J, Huang H. Shi L, et al. Among authors: yan y, yan b. Cancer Res. 2021 Jul 1;81(13):3593-3606. doi: 10.1158/0008-5472.CAN-20-3258. Epub 2021 Mar 24. Cancer Res. 2021. PMID: 33762355

4

Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.

Wang Y, Lei H, Yan B, Zhang S, Xu B, Lin M, Shuai X, Huang J, Pang J. Wang Y, et al. Among authors: yan b. Acta Biomater. 2023 Sep 15;168:593-605. doi: 10.1016/j.actbio.2023.07.018. Epub 2023 Jul 18. Acta Biomater. 2023. PMID: 37474083

5

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis.

Sun R, Yan B, Li H, Ding D, Wang L, Pang J, Ye D, Huang H. Sun R, et al. Among authors: yan b. Cancer Res. 2023 Oct 2;83(19):3192-3204. doi: 10.1158/0008-5472.CAN-23-0285. Cancer Res. 2023. PMID: 37527336 Free PMC article.

6

Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P-Glycoprotein and Ferroptosis.

Guan Y, Lei H, Xing C, Yan B, Lin B, Yang X, Huang H, Kang Y, Pang J. Guan Y, et al. Among authors: yan b. Adv Healthc Mater. 2024 Jan;13(3):e2301345. doi: 10.1002/adhm.202301345. Epub 2023 Nov 8. Adv Healthc Mater. 2024. PMID: 37855250

7

ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment.

Chen H, Xing C, Lei H, Yan B, Zhang H, Tong T, Guan Y, Kang Y, Pang J. Chen H, et al. Among authors: yan b. J Control Release. 2024 Apr;368:637-649. doi: 10.1016/j.jconrel.2024.03.015. Epub 2024 Mar 18. J Control Release. 2024. PMID: 38484895

8

Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy.

Zhang H, Xing C, Yan B, Lei H, Guan Y, Zhang S, Kang Y, Pang J. Zhang H, et al. Among authors: yan b. Biomacromolecules. 2024 Jun 10;25(6):3685-3702. doi: 10.1021/acs.biomac.4c00260. Epub 2024 May 23. Biomacromolecules. 2024. PMID: 38779908

9

Hippo signaling modulation and its biological implications in urological malignancies.

Tong T, Huang M, Yan B, Lin B, Yu J, Teng Q, Li P, Pang J. Tong T, et al. Among authors: yan b. Mol Aspects Med. 2024 Aug;98:101280. doi: 10.1016/j.mam.2024.101280. Epub 2024 Jun 12. Mol Aspects Med. 2024. PMID: 38870717 Review.

10

An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer.

Lin BB, Huang Q, Yan B, Liu M, Zhang Z, Lei H, Huang R, Dong JT, Pang J. Lin BB, et al. Among authors: yan b. Br J Cancer. 2024 Sep;131(5):870-882. doi: 10.1038/s41416-024-02761-0. Epub 2024 Jul 12. Br J Cancer. 2024. PMID: 38997406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,712 results

Search Page

Filters